| 000 | 05696cam a2200457Ii 4500 | ||
|---|---|---|---|
| 001 | 95638 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102112714.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 170324s2017 sz ob 000 0 eng d | ||
| 020 |
_a3319486837 _q(electronic bk.) |
||
| 020 |
_a9783319486833 _q(electronic bk.) |
||
| 020 | _z3319486829 | ||
| 020 | _z9783319486826 | ||
| 040 |
_aN$T _cN$T _dN$T _dEBLCP _dGW5XE _dYDX _dDKU _dOCLCF _dCOO _dAZU _dUPM _dUAB _dMERER _dESU _dOCLCQ _dJBG _dIAD _dICW _dICN _dOTZ _dVT2 _dOCLCQ _dIOG _dOCLCO _dOCLCQ _dJG0 _dU3W _dES-MaUEC _bspa |
||
| 050 | 4 |
_aQR177 _b.D784 2017 EB |
|
| 245 | 0 | 0 |
_aDrug resistance in bacteria, fungi, malaria, and cancer _cGunjan Arora, Andaleeb Sajid, Vipin Chandra Kalia, editors. |
| 264 | 1 |
_aCham, Switzerland _bSpringer _c[2017] |
|
| 264 | 4 | _c2017 | |
| 300 | _a1 recurso en línea | ||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 500 |
_aSpringerLink _bSpringer Biomedical and Life Sciences eBooks 2017 English+International |
||
| 504 | _aIncluye referencias bibliográficas | ||
| 505 | 0 | _aPreface; Contents; Author Biographies; Emerging Themes in Drug Resistance; 1 Pharmacogenomics; 1.1 Introduction; 1.2 Role of Pharmacogenomics in Drug Resistance; 1.2.1 Tuberculosis; 1.2.2 Epilepsy; 1.2.3 HIV; 1.3 Role of Pharmacogenomics in Drug Discovery; 2 Therapeutic Antibodies for Bacterial Diseases; 2.1 The Growing Problem of Antimicrobial Resistance; 2.2 The Need for New Therapeutic Interventions; 2.3 The Foundations of Antibody Therapy; 2.4 Antibody Structure; 2.5 Types of Therapeutic Antibody Molecules; 2.6 Clinical Pipeline; 2.6.1 Neutralization of Viruses and Toxins. | |
| 505 | 8 | _a2.2.2.2 Protection or Modification of the Target2.2.3 Neutralization of the Antibiotic: Warhead Destruction; 2.2.3.1 Hydrolytic Cleavage of the Antibiotic; 2.2.3.2 Addition of Functional Group; 3 Multi-, Extreme- and Pan-Drug Resistance: The Current Threats; 4 Conclusions and Future Perspectives; References; Molecular Mechanism of Drug Resistance; 1 Introduction; 2 Emergence of Drug Resistance: The Road So Far; 2.1 History of Antibiotic Resistance Development: A Problem Getting Worse; 3 Factors for Drug Resistance Development: The Ongoing Phenomena; 4 General Mechanism of Drug Resistance. | |
| 505 | 8 | _a2.6.2 Opsonophagocytic Killing2.6.3 Complement Activation; 2.6.4 Antibody-Drug Conjugates; 2.7 Advantages and Disadvantages of Antibody Therapy; 3 Development of Drug Resistance Through Inter- and Intracellular Communication; 4 Exosome-Mediated Drug Resistance; 4.1 Extracellular Vesicles as Carriers of Drug-Resistant Traits Across Pathologies; 4.2 Vesicle-Mediated Drug Resistance in Noncommunicable Disorders; 4.3 Vesicle-Mediated Drug Resistance in Pathogenic Disorders; 5 Structuromics; 5.1 Role of Structuromics in Deciphering the Drug Resistance Mechanism. | |
| 505 | 8 | _a4.1 Intrinsic Resistance4.2 Acquired Resistance; 5 Drug Resistance Mechanism (Disease Specific); 5.1 Tumor Drug Resistance: An Evolving Paradigm; 5.2 Antibiotic Resistance: The Bacterial Weapons; 5.2.1 Survival Strategies; 5.2.2 Antibiotic Efflux Pump System; 5.2.3 Degradation of Antibiotic; 5.2.4 Alteration of Bacterial Target; 5.3 Tuberculosis: The Unsolved Puzzle; 5.4 Antifungal Drug Resistance; 5.4.1 Antifungal Agents and Their Mechanism of Action; 5.4.2 Ergosterol Biosynthesis Inhibitors (Azoles and Triazoles); 5.4.3 Polyenes; 5.4.4 5-Fluorocytosine: Nucleic Acid Synthesis Inhibitors. | |
| 505 | 8 | _a5.2 Role of Structuromics in Drug Designing6 Posttranslationally Modified Protein Networks as Drug Targets; 7 Conclusions; References; Molecular Mechanism of Drug Resistance: Common Themes; 1 Introduction; 2 Mechanisms of Drug Resistance; 2.1 Intrinsic Resistance; 2.2 Acquired Resistance; 2.2.1 Diminution of Intracellular Antibiotic Load: The External Affairs; 2.2.1.1 Reducing Permeability: The Consular Affairs; 2.2.1.2 Enhancing the Efflux: The Deporting Mechanisms; 2.2.2 Modification of the Target: The Blacking Out; 2.2.2.1 Mutation of the Target. | |
| 520 | 3 | _aThis book is a compilation of past and recent knowledge in the field of emerging drug resistance. The book covers major aspects of drug resistance in bacteria, fungi, malaria, and cancer. Human survival on earth is constantly threatened by disease and syndrome. From the early days, the aim of research in medicine was to find therapeutic agents that can improve the quality of human life. Although humans are dependent on natural compounds from early days their dependence of drugs increased excessively in last century. The advances in chemistry and biology have helped researchers to identify the drugs that have improved treatment of many diseases. The primary factor for treatment of these diseases is dependent on the efficacy of drugs available. The development of resistance to these drugs is one of the major hindrances. Although there are number of books available on this topic, ℓ́ℓdrug resistanceℓ́ℓ biology across kingdoms has never been discussed in a coherent way. | |
| 650 | 7 |
_aResistencia a los medicamentos _2embne _0(OCoLC)fst00898703 _0 _9146972 |
|
| 700 | 1 |
_aArora, Gunjan, _eeditor literario |
|
| 700 | 1 |
_aKalia, Vipin Chandra, _eeditor literario _994146 |
|
| 700 | 1 |
_aSajid, Andaleeb, _eeditor literario |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-48683-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 988 | _aEBOOK, asignarmaterias, EBSPRINGER_2017C | ||
| 998 |
_b02/2018 _dz _e- _zSI |
||
| 999 |
_c95638 _d95638 _x1 |
||